Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide with Peginterferon and Ribavirin for Resistant Hepatitis C
NCT00856804Phase 2Unknown
- Sponsor
- Hospital Universitario Virgen de Valme
- Start
- Mar 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in hepatitis C (HCV), sponsored by Hospital Universitario Virgen de Valme. Status: unknown.
02
Drugs
thalidomide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00856804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856804.